Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

QCLS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

QCLS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Q/c Technologies, Inc.(QCLS US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Q/c Technologies, Inc.(QCLS US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

Chronological SEC Filings

Chronological SEC Filings

Non-Ownership Filings(407)

Expand
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing05:00PM
  • 8-KEntry into a Material Definitive Agreement18 Sep
  • 8-KTermination of a Material Definitive Agreement11 Sep
  • 10-QQ2ended 30 Jun 202612 Aug
  • 8-KTermination of a Material Definitive Agreement2 Jul
  • 10-QQ1ended 31 Mar 202615 May
  • 10-K/AFY 2025ended 31 Dec 202529 Apr
  • 10-KFY 2025ended 31 Dec 202515 Apr
  • NT 10-KFY 2025ended 31 Dec 202531 Mar
  • 8-KChanges in Registrant's Certifying Accountant13 Mar
  • EFFECTNotice of effectiveness18 Feb
  • CORRESPFiling review correspondence12 Feb
  • S-3Registration statement (primary offering)11 Feb
  • 8-KEntry into a Material Definitive Agreement23 Jan
  • DRSDraft registration statement23 Jan
  • 8-KEntry into a Material Definitive Agreement9 Dec 2025
  • 424B3Prospectus filing (Rule 424(b)(3))1 Dec 2025
  • EFFECTNotice of effectiveness1 Dec 2025
  • CORRESPFiling review correspondence25 Nov 2025
  • 10-QQ3ended 30 Sept 202519 Nov 2025

Ownership Filings(171)

Expand
  • Form 4Silverman Joshua2 Oct
  • Form 4/ASilverman Joshua2 Oct
  • Form 3Ehrlichman Yossef22 Sep
  • Form 3Fagan Charles Todd17 Aug
  • Form 4Voss Chelsea Sierra14 May
  • Form 4Friscia Stephen15 Apr
  • Form 4Voss Chelsea Sierra15 Apr
  • Form 4Glass Mitchell15 Apr
  • Form 4White Billy Joe15 Apr
  • Form 4Bernstein Bruce15 Apr
  • Form 4Silverman Joshua15 Apr
  • Form 4Voss Chelsea Sierra30 Jan
  • Form 3Voss Chelsea Sierra30 Jan
  • Form 4PharmaCyte Biotech, Inc.18 Nov 2025
  • SC 13D/AQ/C TECHNOLOGIES, INC.18 Nov 2025
  • Form 4Glass Mitchell17 Nov 2025
  • Form 4White Billy Joe17 Nov 2025
  • Form 4Silverman Joshua14 Nov 2025
  • Form 4Friscia Stephen14 Nov 2025
  • Form 4Bernstein Bruce14 Nov 2025

Non-Ownership Filings(407)

Expand
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing05:00PM
  • 8-KEntry into a Material Definitive Agreement18 Sep
  • 8-KTermination of a Material Definitive Agreement11 Sep
  • 10-QQ2ended 30 Jun 202612 Aug
  • 8-KTermination of a Material Definitive Agreement2 Jul
  • 10-QQ1ended 31 Mar 202615 May
  • 10-K/AFY 2025ended 31 Dec 202529 Apr
  • 10-KFY 2025ended 31 Dec 202515 Apr
  • NT 10-KFY 2025ended 31 Dec 202531 Mar
  • 8-KChanges in Registrant's Certifying Accountant13 Mar
  • EFFECTNotice of effectiveness18 Feb
  • CORRESPFiling review correspondence12 Feb
  • S-3Registration statement (primary offering)11 Feb
  • 8-KEntry into a Material Definitive Agreement23 Jan
  • DRSDraft registration statement23 Jan
  • 8-KEntry into a Material Definitive Agreement9 Dec 2025
  • 424B3Prospectus filing (Rule 424(b)(3))1 Dec 2025
  • EFFECTNotice of effectiveness1 Dec 2025
  • CORRESPFiling review correspondence25 Nov 2025
  • 10-QQ3ended 30 Sept 202519 Nov 2025

Ownership Filings(171)

Expand
  • Form 4Silverman Joshua2 Oct
  • Form 4/ASilverman Joshua2 Oct
  • Form 3Ehrlichman Yossef22 Sep
  • Form 3Fagan Charles Todd17 Aug
  • Form 4Voss Chelsea Sierra14 May
  • Form 4Friscia Stephen15 Apr
  • Form 4Voss Chelsea Sierra15 Apr
  • Form 4Glass Mitchell15 Apr
  • Form 4White Billy Joe15 Apr
  • Form 4Bernstein Bruce15 Apr
  • Form 4Silverman Joshua15 Apr
  • Form 4Voss Chelsea Sierra30 Jan
  • Form 3Voss Chelsea Sierra30 Jan
  • Form 4PharmaCyte Biotech, Inc.18 Nov 2025
  • SC 13D/AQ/C TECHNOLOGIES, INC.18 Nov 2025
  • Form 4Glass Mitchell17 Nov 2025
  • Form 4White Billy Joe17 Nov 2025
  • Form 4Silverman Joshua14 Nov 2025
  • Form 4Friscia Stephen14 Nov 2025
  • Form 4Bernstein Bruce14 Nov 2025